Peer review articles planned or manuscripts submitted for peer review approval and publication in the forthcoming issues.
Online First
Online First articles have been peer reviewed, accepted for publication, and published online; they have not yet been assigned to a journal issue. When an article is published in a journal issue with the assigned page number, it will be removed from the ‘Forthcoming Issue’ page.
Online First articles are copyedited by the science editors and the editorial production team, typeset, and proofread approved by the author before publication. We aim to post each article within six weeks of acceptance and within two weeks after final proofreading approval by the author. Online First articles are in searchable full text, with the initial online publication date included in the final print version.
Articles appearing on the ‘Forthcoming Issue’ page are in the order of the Journal Editorial Sections. You may also view the abstract by clicking on the article link.
Subscribe now to the print or PDF copy of GaBI Journal to view full information of the following manuscripts*.
Letters to the Editor
Challenges to generic medicines utilization in Yemeni healthcare system / Saleh Karamah Al-Tamimi, Associate Professor Mohamed Azmi Hassali, Alian A Alrasheedy, Malaysia
Access to liposomal generic formulations: Beyond Ambisome® and Doxil/Caelyx® / Sara Gaspani, Barbara Milani
Commentary
Commentary on the Guideline of the European Society for Organ Transplantation Advisory Committee on Generic Substitution of Immunosuppressive Drugs / Professor Teun van Gelder, The Netherlands (Generic immunosuppressants in transplantation)
Biologicals in pharmacovigilance―adverse drug reaction (ADR) reporting and traceability / Thijs J Giezen, PharmD, PhD; Sabine MJM Straus, MD, PhD, The Netherlands (Biosimilars for healthcare professionals)
Original Research
Which instruments do sickness funds apply to improve rational use of medicines and generics uptake? A case study from Austria / Sabine Vogler, PhD; Nina Zimmermann, MA, Austria
Regional tenders on biosimilars in Italy: potentially competitive? / S Curto, K van de Vooren, R Lo Muto, S Duranti, L Garattini, Italy (Biosimilars for healthcare professionals)
Assessing biosimilarity using the method of generalized pivotal quantities / Shih-Ting Chiu; Chen Chen; Professor Shein-Chung Chow, PhD; Eric Chi (Biosimilarity and Interchangeability)
Patients knowledge and perception towards generic medicines: findings from a cross sectional survey at a public hospital in Malaysia / Mohamed Azmi Ahmad Hassali, Fahad Saleem, Atisha Abdul Hanif, Catherine Lim TzeYinn, Leong PuiChee, TeohTsyr Fen, Chua Gin Nie, Tahir Mehmood Khan
Survey about availability and price of medicines in hospitals in European countries / Sabine Vogler, PhD, Austria
Review Article
Pharmacokinetics of antimicrobials in obese children / MR Sampson, PharmD; M Cohen-Wolkowiez, MD, PhD; DK Benjamin Jr.; EV Capparelli, PharmD; KM Watt, MD
Generic immunosuppressants comparability studies / Marc Maliepaard, PhD; Professor Hubert G M Leufkens, PharmD, PhD, The Netherlands
Evaluation of pharmacy guidelines, implementation activities, and financial incentives: a fruitful combination / Associate Professor Marc A Koopmanschap, PhD; Maria A Goossensen, PhD; Kor J Grit, PhD; Alexander HE Koolman, PhD, The Netherlands
The lack of chiral considerations in generics testing / Professor Joseph Gal, USA; Professor Andrew J Hutt, UK
Generic drug policies: overview and global market trends / Helle Håkonsen, MscPharm, PhD; Professor Toverud, Norway
The merits of INN prescribing with a focus on oral molecules: introduction, case histories, how to enhance INN prescribing/reduce confusion / Dr Brian Godman, et al. (a total of 10 authors)
WHO pre-qualification programme (design process for the best protocols) – setting up of 20 protocols: critical aspects and pitfalls / Dr Jennifer Dressman, Germany
Bioequivalence – some practical issues and news / Dr Henrike Potthast, BfArM, Germany
Perspective
Why bioequivalence and unconditional interchangeability of generic drugs are not the same / Professor Teun van Gelder, MD, PhD, The Netherlands (Generic immunosuppressants in transplantation)
Equivalence of generic medicines in general and immunosuppressants in particular – a regulatory opinion on switching of cyclosporin, tacrolimus and mycophenolate mofetil / Marc Maliepaard, PhD; Yang Yu, PharmD; Professor Hubert G M Leufkens, PharmD, PhD, The Netherlands (Generic immunosuppressants in transplantation)
Biosimilarity in Latin America / Chiann Chang, PhD; Leonardo de Souza Teixeira, PhD; Fabiana Fernandes de Santana; Silva Cardoso, MSc; Isabela da Costa César, PhD; Gerson Antônio Pianetti, PhD (Biosimilars for healthcare professionals)
Biosimilars in oncology: emerging and future benefits / Professor Matti S Aapro, MD, Switzerland; Dr Paul Cornes, UK (Biosimilars for healthcare professionals)
Biosimilars of monoclonal antibodies–physician’s perspective / Mario Dicato, MD, Luxembourg (Biosimilars for healthcare professionals)
Positive experience in using biosimilar G-CSF in the context of autologus stem cell mobilisation / Kim H Orchard, MD, UK (Biosimilars for healthcare professionals)
Practical experience in the use of G-CSF―pharmacist’s perspective / Dr Jean-Baptiste Rey, et al. (Biosimilars for healthcare professionals)
Current status with biosimilars: payer’s perspective / Corrine Zara, PharmD, Spain; Dr Brian Godman, UK (Biosimilars for healthcare professionals)
Pharmacist’s expectations on the use of biosimilars / Professor Alain Astier, PharmD, PhD, France (Biosimilars for healthcare professionals)
Special Report
Understanding the components of pharmaceutical expenditure – Overview of pharmaceutical policies influencing expenditure across European countries / Sabine Vogler, PhD; Nina Zimmermann, MA; Mag. Claudia Habl, Austria
Guidelines
Biosimilar development and regulation in Japan / Ms Teruyo Arato, Japan (Biosimilars for healthcare professionals)
European biosimilar monoclonal antibody guidelines: an overview (Biosimilars for healthcare professionals)
Update on clinical practice guideline on the use of epoetin and darbepoetin in adult patients with cancer / Julie Clayton, PhD, GaBI Journal Editor
Regulatory
Comparability of biologicals that is arising: discussion and litigation about supplementary protection certificates / John Lisman, The Netherlands (Biosimilars for healthcare professionals)
For Patients
IAPO breifing paper on biosimilar medicines / Yasemin Dil, UK
Conference Report
Recent trends and special topics in drug review in PMDA / Toshiki Sugita, PhD, Japan
Others
Biosimilars judgement/selection systems / Dr Robert Janknegt; Professor Arnold Vulto, The Netherlands (Biosimilars for healthcare professionals)
Clinical aspects and practical application by clinician and hospital pharmacist: prescriptions, substitution and pharmacovigilance / Professor Francesco Locatelli, Dr Paola Minghetti, Italy (Biosimilars for healthcare professionals)
Click here for more details on the educational series.
Contact us for an updated list of editorial topics in forthcoming issues.
*Editorial content may differ from final version of manuscript published in print.